Madison Scientific

Coming – August 11

Beyond Billy Joel: A New Approach to Treating Hydrocephalus

Date and Time

August 11

–

4:00 PM ET / 1:00 PM PT

Details will be provided upon RSVP approval

About this Event

When Billy Joel revealed that he had been diagnosed with normal pressure hydrocephalus, millions of people heard the name of the disease for the first time. His diagnosis has helped shine a spotlight on a neurological condition that is often misunderstood, frequently misdiagnosed, and affects millions of people worldwide. Experts say earlier diagnosis and better treatment can dramatically improve quality of life, yet today’s standard treatment has changed little in decades.

Join us for an exclusive Executive Briefing with Dr. Tyler Wanke, CEO of MadSci (Madison Scientific), for an update on the company’s progress developing SmartShunt, an intelligent hydrocephalus treatment designed to address one of the biggest challenges facing patients and physicians today: shunt failure. MadSci’s technology combines a smart valve, intracranial pressure sensing, and continuous monitoring to reduce complications while providing physicians with real-time clinical data. The company has completed initial bench and animal studies and is advancing toward the next phase of development.

During the discussion, Tyler will provide an update on SmartShunt’s development, explain why hydrocephalus may represent one of the largest underserved opportunities in neurological medicine, and discuss the commercial potential of a market that could ultimately exceed $100 billion globally as awareness, diagnosis, and treatment continue to expand.

You’ll learn:
  • Why Billy Joel’s diagnosis has increased awareness of hydrocephalus and why that matters for patients and healthcare.
  • The shortcomings of today’s shunt technology and why failure rates remain so high.
  • How MadSci’s SmartShunt is designed to improve outcomes while reducing unnecessary healthcare utilization.
  • The company’s latest development milestones and commercialization strategy.
  • Why many believe hydrocephalus is one of the largest untapped opportunities in neurotechnology.

We hope you’ll join us for what promises to be a fascinating discussion about an important medical challenge, the technology that could transform patient care, and the opportunity to build the next generation of smart neurotechnology.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.